查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2002926

工業微生物市場：全球市場按產品類型、技術、微生物類型、應用和最終用戶分類的預測 - 2026-2032 年

Industrial Microbiology Market by Product Type, Technology, Organism Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，工業微生物市場價值將達到 197.6 億美元，到 2026 年將成長到 212.1 億美元，到 2032 年將達到 350.3 億美元，複合年成長率為 8.52%。

主要市場統計數據
基準年 2025 197.6億美元
預計年份：2026年 212.1億美元
預測年份 2032 350.3億美元
複合年成長率 (%) 8.52%

從前瞻性的角度展示了工業微生物學如何整合技術創新、業務規模化和監管合規性，從而實現跨行業的商業性應用。

工業微生物學正迅速從一個專業科學領域發展成為支撐永續製造、治療方法創新和循環經濟舉措的策略引擎。如今，它與先進的生物製程工程、電腦輔助菌株設計以及新興的原料供應鏈相融合，正在改變企業對生產風險、產品上市時間和成本結構的認知。投資者和技術領袖不僅關注生物系統的能力，也關注支撐這些能力的生態系統——可擴展的生物反應器、可重複的下游工作流程以及促進工業應用的監管途徑。

整合關鍵的技術、監管、金融和永續性驅動的變革，重新定義工業微生物學的競爭和營運模式。

工業微生物學的格局正因技術、政策和市場預期的整合而轉變，這些轉變既改變了機遇，也增加了實施風險。合成生物學和自動化菌株工程的進步縮短了研發週期，並降低了早期失敗率。同時，生物反應器控制和下游製程的改進提高了產量穩定性，降低了大規模生產的波動性。同時，永續發展需求和企業淨零排放承諾正推動市場轉向生物基原料和循環製造方式，迫使各組織重新評估原料採購和生命週期指標。

美國近期貿易措施至2025年將如何影響工業微生物相關人員在生物製程原料、設備採購和策略採購選擇方面的綜合分析

美國近期推出的關稅措施和貿易政策調整將持續到2025年，這將為生物製藥原料和設備的整個供應鏈帶來額外的成本和物流複​​雜性，產業領導者需要預見這些連鎖反應。對進口實驗室設備、特殊化學品或某些發酵耗材徵收的關稅推高了原料的採購成本，如果國內沒有替代供應商，可能會導致資本計劃延期。這些變化將影響供應商的選擇決策，以及企業在多大程度上優先考慮在地採購、回流生產或策略性庫存緩衝以保障關鍵營運。

以細分為導向的全面觀點，將產品類型、應用領域、最終用戶概況、技術模式和物種連結起來，從而確定開發路徑和商業性可行性的優先順序。

從細分市場層面進行分析，可以發現哪些領域的技術發展與商業性需求相契合，哪些領域的營運限制阻礙了技術的應用。以產品為中心的細分市場包括胺基酸、抗生素、生質燃料、生質塑膠、酵素和維生素。酵素在這一框架下特別值得關注，因為其下游商業化路徑會因目標市場（例如動物飼料、清潔劑和食品加工）的不同而有所差異，每個目標市場都有其獨特的配方和監管要求。以應用領域為中心的細分市場涵蓋農業、生質燃料、環境修復、食品飲料和製藥。在製藥領域，藥物發現和製劑開發的動態變化會影響研發進度和監管複雜性，進而導致投資格局的多元化。

此戰略區域評估確定了美洲、歐洲、中東和非洲以及亞太地區的創新叢集、製造業優勢和政策環境，並有助於制定全球部署計劃。

地理趨勢持續影響技術實力、監管清晰度和資本匯聚的地點，從而形成創新和製造能力中心。在美洲，成熟的生物技術產業叢集支撐著從研發到生產的一體化價值鏈，並得到深厚的創業投資網路和成熟的合約研發生產（CDMO）生態系統的支持。該地區通常在連接藥物發現和規模化生產的轉化平台中發揮主導作用。歐洲、中東和非洲地區呈現出多元化的格局，歐洲部分地區監管嚴格，而對在其他地區生產的需求卻日益成長。此外，以永續性為重點的政策舉措正在推動對生質塑膠和可再生生物基解決方案的需求。

檢驗決定競爭優勢的企業策略和營運能力，例如平台所有權、垂直整合、夥伴關係和人力資本實力。

從公司層面來看，趨勢揭示了各公司競爭地位的形成源自於其獨特的技術平台、製造能力和銷售管道組合。一些公司專注於平台菌株的工程設計和許可，構建豐富的知識產權組合和模組化技術套件，從而實現快速客製化。另一些公司則追求垂直整合，將菌株開發與專有的發酵過程和下游純化相結合，以縮短獲利時間。還有一些公司作為靈活的服務供應商和契約製造運營，為沒有自有設施的新興研發公司提供規模化生產和生產能力。無論採用何種模式，成功的公司都展現出嚴謹的計劃執行、強大的品管體係以及將實驗室可重複性轉化為穩定工業化生產的能力。

為領導者提供行動導向的建議，以加強供應鏈、實現製造柔軟性現代化、整合監管前瞻性以及協調商業性夥伴關係，從而實現快速規模化。

產業領導者必須優先考慮兼顧創新與業務永續營運連續性的實際措施。首先，實現供應商多元化並加強合格通訊協定，以減少對關鍵設備、試劑和耗材單一來源的依賴。這將有助於降低貿易中斷帶來的風險，並確保可預測的規模化生產時間表。其次，投資於模組化和靈活的生產設備，以實現快速的產品切換，並相容於液態和固體發酵方法，從而最佳化原料利用率和製程經濟性，而無需考慮產品類型或終端市場。

概述了高度透明的調查方法，描述了用於得出有效和可操作結論的主要訪談、次要技術分析、細分映射和情境測試。

本分析的調查方法結合了定性和定量方法，旨在確保技術可信度和商業性相關性。主要研究包括對行業高管、技術領導者、採購專家和監管顧問進行結構化訪談，以獲取關於營運限制、策略重點和新興機會的第一手觀點。次要研究整合了同行評審文獻、專利趨勢、監管指導文件和企業資訊披露，以檢驗技術聲明並追蹤不同微生物物種和工藝架構中技術的成熟路徑。

一份簡明扼要的總結證實，要使工業微生物學領域的技術創新實現永續的市場影響，營運、監管和商業性能力的整合是必不可少的。

結論總結了報告的核心觀點：工業微生物學正日趨成熟，成為一個策略性領域，而實現商業性成功不僅需要技術創新，還需要切實可行的營運設計和監管前瞻性。那些將平台級菌株工程與靈活的生產策略和多元化的採購管道結合的企業，更有能力應對政策變化和供應鏈中斷。區域差異持續影響企業優先分配資本的領域，而基於市場區隔的策略則揭示了特定產品類型和終端市場最可行的發展路徑。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 工業微生物市場：依產品類型分類

  • 胺基酸
  • 抗生素
  • 生質燃料
  • 生質塑膠
  • 酵素
    • 飼料
    • 清潔劑
    • 食品加工
  • 維他命

第9章 工業微生物市場：依技術分類

  • 生物反應器
  • 細胞培養
  • 下游工藝
  • 發酵
    • 固體發酵
    • 浸沒式發酵

第10章 依物種分類的工業微生物市場

  • 藻類
  • 細菌
    • 革蘭氏陰性菌
    • 革蘭氏陽性菌
  • 真菌
  • 酵母菌

第11章 工業微生物市場：依應用領域分類

  • 農業
  • 生質燃料
  • 環境
  • 食品/飲料
  • 製藥
    • 藥物發現
    • 配方

第12章 工業微生物市場：依最終用戶分類

  • 農業企業
  • 環保組織
  • 食品製造商
  • 製藥公司
  • 研究機構

第13章 工業微生物市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 工業微生物市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 工業微生物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國工業微生物市場

第17章：中國工業微生物市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Agilent Technologies, Inc.
  • Ajinomoto Co., Inc.
  • Archer Daniels Midland Company
  • Avantor, Inc.
  • BASF SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Chr. Hansen Holding A/S
  • Danaher Corporation
  • DuPont de Nemours, Inc.
  • Eppendorf SE
  • Eurofins Scientific SE
  • Evonik Industries AG
  • Hardy Diagnostics
  • HiMedia Laboratories Private Limited
  • Hy Laboratories Ltd.
  • Kerry Group plc
  • Koninklijke DSM NV
  • Lonza Group AG
  • Merck KGaA
  • Neogen Corporation
  • Novozymes A/S
  • QIAGEN NV
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-957C47F92627

The Industrial Microbiology Market was valued at USD 19.76 billion in 2025 and is projected to grow to USD 21.21 billion in 2026, with a CAGR of 8.52%, reaching USD 35.03 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.76 billion
Estimated Year [2026] USD 21.21 billion
Forecast Year [2032] USD 35.03 billion
CAGR (%) 8.52%

A forward-looking orientation describing how industrial microbiology integrates technical innovation, operational scaling, and regulatory navigation to enable commercial adoption across industries

Industrial microbiology is rapidly evolving from a specialized scientific discipline into a strategic engine for sustainable manufacturing, therapeutic innovation, and circular economy initiatives. The field now intersects advanced bioprocess engineering, computational strain design, and emergent feedstock supply chains in ways that change how companies conceive of production risk, time to market, and cost structures. Investors and technology leaders are focusing not only on the capabilities of biological systems but on the ecosystem that enables them: scalable bioreactors, reproducible downstream workflows, and regulatory pathways that permit industrial adoption.

This introduction situates the reader at the nexus of science and commercialization. It establishes the core domains-product classes that include high-value molecules and bulk bio-based materials, application areas from agriculture to environmental remediation, and the institutional users who operate or procure these technologies. It emphasizes the imperative for robust analytical pipelines and cross-functional collaboration between R&D, regulatory, and operations teams. By clarifying the drivers that currently shape decision-making, this section prepares leaders to interpret detailed analyses and to prioritize investments that deliver technical maturity and market relevance within realistic timelines.

A synthesis of the key technological, regulatory, financial, and sustainability-driven changes reshaping industrial microbiology and redefining competitive and operational models

The landscape of industrial microbiology is being transformed by converging shifts in technology, policy, and market expectations that alter both opportunity and execution risk. Advances in synthetic biology and automated strain engineering have shortened development cycles and reduced failure rates at early stages, while improvements in bioreactor control and downstream processing have increased yield consistency and reduced variability at scale. At the same time, sustainability imperatives and corporate net-zero commitments are reshaping demand toward bio-based inputs and circular manufacturing approaches, pushing organizations to re-evaluate feedstock sourcing and life-cycle metrics.

Regulatory frameworks are also evolving, with authorities clarifying requirements for genetically modified organisms, environmental releases, and product labeling. This regulatory momentum accelerates or constrains commercialization depending on alignment with compliance pathways and with public acceptance. Financing patterns are shifting as well: investors demonstrate growing interest in platform technologies and vertically integrated plays that combine strain development with manufacturing control. Finally, the increased availability of modular and distributed production systems is enabling new business models, including contract development and manufacturing, decentralized microfactories, and pay-per-output service arrangements, which collectively alter how companies scale and compete.

An integrated analysis of how recent United States trade measures through 2025 affect bioprocess inputs, equipment procurement, and strategic sourcing choices for industrial microbiology stakeholders

Recent tariff actions and trade policy adjustments in the United States through 2025 have introduced additional layers of cost and logistical complexity across biologics inputs and equipment supply chains, with ripple effects that industry leaders must anticipate. Tariffs that target imported laboratory equipment, specialty chemicals, or certain fermentation consumables elevate landed input costs and can delay capital projects when alternative suppliers are not available domestically. These shifts influence supplier qualification decisions and the degree to which organizations prioritize local sourcing, onshoring, or strategic inventory buffering to protect critical operations.

Beyond immediate cost implications, tariff-driven supply chain realignments change procurement strategies and partnership models. Entities reliant on specialized foreign bioreactor components or proprietary reagents face longer lead times and potential single-source risks, which increases the value of multi-sourcing assessments and vendor resiliency planning. Conversely, some domestic suppliers and integrators may see expanded demand as firms accelerate qualification of local alternatives. Firms must also weigh the indirect impacts: increased administrative burden for customs compliance, shifting freight dynamics, and the potential for policy volatility that complicates long-term capital budgeting. To respond effectively, organizations should integrate tariff sensitivity scenarios into sourcing, risk management, and procurement roadmaps while continuing to monitor policy developments and diplomatic shifts that affect global trade flows.

A comprehensive segmentation-driven perspective linking product categories, application domains, end-user profiles, technology modalities, and organism types to prioritize development pathways and commercial fit

Segment-level understanding reveals where technical development aligns with commercial demand and where operational constraints constrain adoption. Product-focused segmentation spans amino acids, antibiotics, biofuels, bioplastics, enzymes, and vitamins; within this frame, enzymes warrant special attention because their downstream commercialization paths differ depending on target markets such as animal feed, detergents, and food processing, each with distinct formulation and regulatory requirements. Application segmentation covers agriculture, biofuels, environmental remediation, food and beverage, and pharmaceuticals, and within pharmaceuticals the dynamics of drug discovery versus drug formulation influence timelines and regulatory complexity, creating divergent investment profiles.

End-user segmentation differentiates agriculture firms, environmental agencies, food manufacturers, pharmaceutical companies, and research institutes, which in turn determine procurement cadence, risk tolerance, and long-term partnership expectations. Technology segmentation emphasizes bioreactors, cell culture, downstream processing, and fermentation, where fermentation further divides into solid state and submerged approaches that vary by robustness, capital intensity, and feedstock flexibility. Organism type segmentation distinguishes algae, bacteria, fungi, and yeast, and the bacterial category subdivides into Gram-negative and Gram-positive strains, which carry different genetic toolkits and containment considerations. Synthesizing these segmentation layers clarifies where synergistic investments-such as pairing submerged fermentation expertise with Gram-positive production hosts for specific enzyme outputs-deliver accelerated commercialization, and where mismatches between end-user needs and technological maturity create friction that demands targeted development or partnership strategies.

A strategic regional appraisal identifying innovation clusters, manufacturing strengths, and policy environments across the Americas, Europe Middle East & Africa, and Asia-Pacific to inform global deployment plans

Geographic dynamics continue to influence where technological capability, regulatory clarity, and capital converge to create hubs of innovation and manufacturing capacity. In the Americas, established industrial biotech clusters support integrated development-to-manufacturing value chains, strengthened by deep venture capital networks and mature CDMO ecosystems; this region often leads in translational platforms that bridge discovery and scale-up. Europe, Middle East & Africa exhibits a heterogeneous landscape where regulatory sophistication in parts of Europe coexists with emerging manufacturing ambitions elsewhere, and where sustainability-oriented policy initiatives drive demand for bioplastics and renewable bio-based solutions.

Asia-Pacific is characterized by rapid capacity expansion, aggressive public and private investment in bioindustrial parks, and strong supply-chain integration with upstream feedstock producers and downstream processors. Regional specialization matters: certain countries within each region prioritize pharmaceuticals and biologics, while others focus on bulk biofuels or enzymes for industrial use, influencing how companies approach partnerships, technology transfer, and regulatory alignment. Cross-border considerations, such as trade agreements, intellectual property protection, and regional standards harmonization, continue to shape where companies establish R&D centers and manufacturing footprints. Decision-makers must therefore assess regional advantages not only in isolation but as part of a multi-jurisdictional strategy that optimizes proximity to customers, robustness of supply chains, and regulatory alignment.

An examination of corporate strategies and operational capabilities that determine competitive advantage including platform ownership, vertical integration, partnerships, and human capital strengths

Company-level dynamics reveal competitive positioning that stems from unique combinations of technological platforms, manufacturing capability, and commercial channels. Some firms concentrate on platform strain engineering and licensing, building deep IP estates and modular technology suites designed for rapid customization, while others vertically integrate to combine strain development with proprietary fermentation processes and downstream purification that shorten paths to revenue. A third cohort operates as flexible service providers and contract manufacturers, offering scale-up and production capacity to emerging developers who lack in-house facilities. Across these models, successful companies demonstrate disciplined project execution, robust quality systems, and the ability to translate laboratory reproducibility into consistent industrial output.

Collaborative behavior also differentiates leaders: those that form cross-sector partnerships with feedstock suppliers, regulatory consultants, and offtake customers can de-risk early commercial runs and accelerate adoption. Strategic alliances with equipment suppliers and automation vendors further strengthen operational performance. Additionally, investments in digital process control and analytics separate organizations that can reliably scale from those that struggle with variability. Finally, human capital-experienced fermentation scientists, regulatory affairs professionals, and operations managers-remains a critical differentiator, enabling firms to execute complex projects and to respond rapidly to technical or regulatory challenges.

Action-oriented recommendations for leaders to fortify supply chains, modernize manufacturing flexibility, integrate regulatory foresight, and align commercial partnerships for rapid scale-up

Industry leaders must prioritize pragmatic actions that balance innovation with operational resilience. First, strengthen supplier diversification and qualification protocols to reduce single-source exposure for critical equipment, reagents, and consumables; this reduces vulnerability to trade disruptions and supports predictable scale-up timelines. Next, invest in modular and flexible manufacturing assets that enable rapid product changeover and that accommodate both submerged and solid state fermentation modalities to optimize feedstock use and process economics across product types and end markets.

Firms should also embed regulatory intelligence early in development programs, aligning strain engineering and process design with foreseeable compliance pathways to reduce time-to-approval friction for pharmaceuticals, food applications, and environmental releases. Cross-functional integration between R&D, operations, and commercial functions will enhance prioritization and ensure that technical milestones translate into buyer-validated specifications. Leaders should pursue strategic partnerships that secure offtake or feedstock contracts, and they should explore co-investment arrangements with local manufacturing partners to mitigate capital intensity and to accelerate market entry. Finally, cultivating workforce skills in bioprocess automation, quality systems, and data analytics will ensure that organizations can sustain reproducible manufacturing and continuous improvement.

A transparent methodological overview describing primary interviews, secondary technical analysis, segmentation mapping, and scenario testing used to produce defensible and actionable conclusions

The research methodology underpinning this analysis combined qualitative and quantitative approaches designed to ensure technical credibility and commercial relevance. Primary research included structured interviews with industry executives, technical leaders, procurement specialists, and regulatory advisors to capture firsthand perspectives on operational constraints, strategic priorities, and emergent opportunities. Secondary research synthesized peer-reviewed literature, patent landscapes, regulatory guidance documents, and company disclosures to validate technical claims and to trace technology maturation paths across organism types and process modalities.

Analytical techniques included cross-segmentation mapping to identify where product types align with specific technology stacks and end-user requirements, scenario analysis to test the sensitivity of sourcing and operational assumptions to policy and trade developments, and comparative capability assessments to benchmark firm-level strengths. Throughout the process, findings were triangulated across multiple sources to reduce bias and to highlight both consensus views and material disagreements. This methodology supports robust conclusions while allowing for nuanced interpretation tailored to specific organizational contexts and strategic questions.

A concise synthesis reinforcing that technical innovation in industrial microbiology requires integrated operational, regulatory, and commercial capabilities to realize durable market impact

The conclusion synthesizes the report's central insights: industrial microbiology is maturing into a strategic domain where technical innovation must be matched by pragmatic operational design and regulatory foresight to achieve commercial outcomes. Organizations that pair platform-level strain engineering with flexible manufacturing strategies and diversified sourcing are best positioned to navigate policy shifts and supply-chain disruptions. Regional differences will continue to influence where firms prioritize capital deployment, while segmentation-informed strategies illuminate the most viable paths for specific product types and end markets.

Leaders should treat the current moment as an opportunity to translate technological capability into resilient business models by accelerating investments in process analytics, workforce development, and partnership ecosystems. By doing so, they can reduce execution risk, capture early adopter advantages in sustainability-oriented markets, and position their organizations to respond nimbly to evolving regulatory and trade conditions. The cumulative message is clear: technical excellence alone is necessary but insufficient; commercial success depends on integrated capability across development, manufacturing, procurement, and market engagement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Industrial Microbiology Market, by Product Type

  • 8.1. Amino Acids
  • 8.2. Antibiotics
  • 8.3. Biofuels
  • 8.4. Bioplastics
  • 8.5. Enzymes
    • 8.5.1. Animal Feed
    • 8.5.2. Detergents
    • 8.5.3. Food Processing
  • 8.6. Vitamins

9. Industrial Microbiology Market, by Technology

  • 9.1. Bioreactor
  • 9.2. Cell Culture
  • 9.3. Downstream Processing
  • 9.4. Fermentation
    • 9.4.1. Solid State Fermentation
    • 9.4.2. Submerged Fermentation

10. Industrial Microbiology Market, by Organism Type

  • 10.1. Algae
  • 10.2. Bacteria
    • 10.2.1. Gram Negative
    • 10.2.2. Gram Positive
  • 10.3. Fungi
  • 10.4. Yeast

11. Industrial Microbiology Market, by Application

  • 11.1. Agriculture
  • 11.2. Biofuels
  • 11.3. Environmental
  • 11.4. Food And Beverage
  • 11.5. Pharmaceuticals
    • 11.5.1. Drug Discovery
    • 11.5.2. Drug Formulation

12. Industrial Microbiology Market, by End User

  • 12.1. Agriculture Firms
  • 12.2. Environmental Agencies
  • 12.3. Food Manufacturers
  • 12.4. Pharmaceutical Companies
  • 12.5. Research Institutes

13. Industrial Microbiology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Industrial Microbiology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Industrial Microbiology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Industrial Microbiology Market

17. China Industrial Microbiology Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Agilent Technologies, Inc.
  • 18.7. Ajinomoto Co., Inc.
  • 18.8. Archer Daniels Midland Company
  • 18.9. Avantor, Inc.
  • 18.10. BASF SE
  • 18.11. Becton, Dickinson and Company
  • 18.12. Bio-Rad Laboratories, Inc.
  • 18.13. bioMerieux SA
  • 18.14. Chr. Hansen Holding A/S
  • 18.15. Danaher Corporation
  • 18.16. DuPont de Nemours, Inc.
  • 18.17. Eppendorf SE
  • 18.18. Eurofins Scientific SE
  • 18.19. Evonik Industries AG
  • 18.20. Hardy Diagnostics
  • 18.21. HiMedia Laboratories Private Limited
  • 18.22. Hy Laboratories Ltd.
  • 18.23. Kerry Group plc
  • 18.24. Koninklijke DSM N.V.
  • 18.25. Lonza Group AG
  • 18.26. Merck KGaA
  • 18.27. Neogen Corporation
  • 18.28. Novozymes A/S
  • 18.29. QIAGEN N.V.
  • 18.30. Sartorius AG
  • 18.31. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 205. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 207. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 209. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 235. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 239. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 245. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 247. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 249. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)